Researchers seek new weapon against the flu.
Service
R F
RF
D000284:Administration, Oral; D000588:Amines / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use*; D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use*; D001665:Binding Sites; D002986:Clinical Trials as Topic; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D008565:Membrane Proteins / Q000235:genetics* / Q000502:physiology; D015394:Molecular Structure; D009439:Neuraminidase / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D009975:Orthomyxoviridae / Q000187:drug effects* / Q000201:enzymology; D053139:Oseltamivir; D010940:Plant Proteins; D011487:Protein Conformation
D000588:Amines; D000998:Antiviral Agents; C103918:Hs1 pro-1 protein, Beta procumbens; D008565:Membrane Proteins; D010940:Plant Proteins; D053139:Oseltamivir; D009439:Neuraminidase